Literature DB >> 26246155

Frequent genomic rearrangements of BRCA1 associated protein-1 (BAP1) gene in Japanese malignant mesothelioma-characterization of deletions at exon level.

Mitsuru Emi1,2, Yoshie Yoshikawa1, Chika Sato3, Ayuko Sato4, Hidenori Sato5, Takeo Kato5, Tohru Tsujimura4, Seiki Hasegawa6, Takashi Nakano7, Tomoko Hashimoto-Tamaoki1.   

Abstract

Malignant mesothelioma (MM) is an asbestos-related malignancy arising from surface serosal cells of pleural and peritoneal cavities. Somatic mutations of BRCA1 associated protein-1 (BAP1) gene were recently found in MM as well as in uveal melanoma and kidney cancer among the Caucasian and Japanese people. However, frequency of mutations varies among the reported studies, which might be due to presence of undetected gross rearrangements of BAP1 gene that might escape detection by sequencing strategy. We investigated the presence and frequency of gross genomic rearrangements in the BAP1 gene by multiplex ligation-dependent probe amplification (MLPA) in 17 Japanese cases of MM tumors. We found five tumors with partial deletion of BAP1 gene; each tumors displayed partial deletion of exons 1-4 (MM39), exons 1-5 (MM48), exons 11-17 (MM57), exons 1-15 (MM19) and exons 1-16 (MM21). Two tumors (MM34, MM14) had biallelic deletion and four tumors (MM29, MM35, MM45 and MM56) had monoallelic deletion of entire BAP1 gene. Therefore, MLPA analysis revealed large gene rearrangements of BAP1 gene in 65% of MM (11/17). Unusually high frequency of large deletions indicates that the 3p21 chromosomal region surrounding BAP1 gene is structurally unstable. MLPA was useful in characterizing both monoallelic and biallelic deletion of BAP1 gene precisely at exon level.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26246155     DOI: 10.1038/jhg.2015.91

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  13 in total

1.  Asbestos is not just asbestos: an unrecognised health hazard.

Authors:  Francine Baumann; Jean-Paul Ambrosi; Michele Carbone
Journal:  Lancet Oncol       Date:  2013-06       Impact factor: 41.316

Review 2.  Malignant mesothelioma: facts, myths, and hypotheses.

Authors:  Michele Carbone; Bevan H Ly; Ronald F Dodson; Ian Pagano; Paul T Morris; Umran A Dogan; Adi F Gazdar; Harvey I Pass; Haining Yang
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

3.  Frequent mutation of BAP1 in metastasizing uveal melanomas.

Authors:  J William Harbour; Michael D Onken; Elisha D O Roberson; Shenghui Duan; Li Cao; Lori A Worley; M Laurin Council; Katie A Matatall; Cynthia Helms; Anne M Bowcock
Journal:  Science       Date:  2010-11-04       Impact factor: 47.728

4.  The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.

Authors:  Matthew Bott; Marie Brevet; Barry S Taylor; Shigeki Shimizu; Tatsuo Ito; Lu Wang; Jenette Creaney; Richard A Lake; Maureen F Zakowski; Boris Reva; Chris Sander; Robert Delsite; Simon Powell; Qin Zhou; Ronglai Shen; Adam Olshen; Valerie Rusch; Marc Ladanyi
Journal:  Nat Genet       Date:  2011-06-05       Impact factor: 38.330

5.  Germline alterations in the CDH1 gene in familial gastric cancer in the Japanese population.

Authors:  Hidetaka Yamada; Kazuya Shinmura; Hiroaki Ito; Masako Kasami; Naomi Sasaki; Hideyuki Shima; Masami Ikeda; Hong Tao; Masanori Goto; Takachika Ozawa; Toshihiro Tsuneyoshi; Fumihiko Tanioka; Haruhiko Sugimura
Journal:  Cancer Sci       Date:  2011-08-19       Impact factor: 6.716

6.  High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma.

Authors:  Masaki Nasu; Mitsuru Emi; Sandra Pastorino; Mika Tanji; Amy Powers; Hugh Luk; Francine Baumann; Yu-An Zhang; Adi Gazdar; Shreya Kanodia; Maarit Tiirikainen; Erin Flores; Giovanni Gaudino; Michael J Becich; Harvey I Pass; Haining Yang; Michele Carbone
Journal:  J Thorac Oncol       Date:  2015-04       Impact factor: 15.609

7.  Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma.

Authors:  Guangwu Guo; Juliann Chmielecki; Chandra Goparaju; Adriana Heguy; Igor Dolgalev; Michele Carbone; Sara Seepo; Matthew Meyerson; Harvey I Pass
Journal:  Cancer Res       Date:  2014-12-08       Impact factor: 12.701

8.  Identification of the first case of germline duplication of BRCA1 exon 13 in an Italian family.

Authors:  Roberta Cerutti; Nora Sahnane; Ileana Carnevali; Daniela Furlan; Maria Grazia Tibiletti; Anna Maria Chiaravalli; Carlo Capella
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

Review 9.  Multiplex ligation-dependent probe amplification (MLPA) in tumor diagnostics and prognostics.

Authors:  Cornelia Hömig-Hölzel; Suvi Savola
Journal:  Diagn Mol Pathol       Date:  2012-12

10.  Germline BAP1 mutations predispose to malignant mesothelioma.

Authors:  Joseph R Testa; Mitchell Cheung; Jianming Pei; Jennifer E Below; Yinfei Tan; Eleonora Sementino; Nancy J Cox; A Umran Dogan; Harvey I Pass; Sandra Trusa; Mary Hesdorffer; Masaki Nasu; Amy Powers; Zeyana Rivera; Sabahattin Comertpay; Mika Tanji; Giovanni Gaudino; Haining Yang; Michele Carbone
Journal:  Nat Genet       Date:  2011-08-28       Impact factor: 38.330

View more
  2 in total

1.  Germline large deletion of BAP1 and decreased expression in non-tumor choroid in uveal melanoma patients with high risk for inherited cancer.

Authors:  Getachew Boru; Timothy W Grosel; Robert Pilarski; Meredith Stautberg; James B Massengill; Joanne Jeter; Arun Singh; Meghan J Marino; Joseph P McElroy; Frederick H Davidorf; Colleen M Cebulla; Mohamed H Abdel-Rahman
Journal:  Genes Chromosomes Cancer       Date:  2019-04-23       Impact factor: 5.006

Review 2.  Biological Mechanisms and Clinical Significance of BAP1 Mutations in Human Cancer.

Authors:  Michele Carbone; J William Harbour; James Brugarolas; Angela Bononi; Ian Pagano; Anwesha Dey; Thomas Krausz; Harvey I Pass; Haining Yang; Giovanni Gaudino
Journal:  Cancer Discov       Date:  2020-07-20       Impact factor: 38.272

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.